In a new piece in Science, Naomi Oreskes argues that the postwar bargain between American science and the federal government can no longer be taken for granted. As public funding falters, private money is moving to fill the gap. That brings a familiar risk: funders quietly reshaping the research agenda.
How much does it really cost to answer a tough scientific question? We recently attended a glyphosate symposium. It was fascinating to hear the state of modern science around glyphosate from toxicologists, epidemiologists, regulatory scientists, and advocates. One theme that caught our attention was how "expensive" these experiments
The Bayer slogan behind a federal act invocation. Here Nina B. Elkadi and Naomi Oreskes discuss President Trump's invocation of the Defense Production Act to boost glyphosate (Roundup) production, arguing that the "national security" framing is unwarranted since the herbicide is primarily used on crops for
External Publications
In her latest opinion piece for The BMJ (British Medical Journal), Naomi Oreskes examines the US Environmental Protection Agency's recent actions on climate science and glyphosate. These moves, she argues, are not really about science — they are about dismantling the regulatory state. The administration repealed the greenhouse gas